These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 32757711

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Case of eosinophilic myositis in continuum from localized nodular myositis].
    Matsuse D, Ikezoe K, Shigeto H, Murai H, Ohyagi Y, Kira J.
    Rinsho Shinkeigaku; 2008 Jan; 48(1):36-42. PubMed ID: 18386630
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Recovery from hypoxemia and Hypercapnia following noninvasive pressure support ventilation in a patient with statin-associated necrotizing myopathy: a case report.
    Yamamura Y, Matsumoto Y, Tadokoro K, Ohta Y, Sato K, Yamashita T, Yamamura M, Sada KE, Abe K, Wada J.
    BMC Pulm Med; 2020 Jun 03; 20(1):156. PubMed ID: 32493279
    [Abstract] [Full Text] [Related]

  • 7. Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial.
    Kobayashi T, Motoya S, Nakamura S, Yamamoto T, Nagahori M, Tanaka S, Hisamatsu T, Hirai F, Nakase H, Watanabe K, Matsumoto T, Tanaka M, Abe T, Suzuki Y, Watanabe M, Hibi T, HAYABUSA Study Group.
    Lancet Gastroenterol Hepatol; 2021 Jun 03; 6(6):429-437. PubMed ID: 33887262
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report.
    Kamo H, Hatano T, Kanai K, Aoki N, Kamiyama D, Yokoyama K, Takanashi M, Yamashita Y, Shimo Y, Hattori N.
    BMC Neurol; 2019 Aug 05; 19(1):184. PubMed ID: 31382909
    [Abstract] [Full Text] [Related]

  • 11. Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis.
    Panaccione R, Ghosh S, Middleton S, Márquez JR, Scott BB, Flint L, van Hoogstraten HJ, Chen AC, Zheng H, Danese S, Rutgeerts P.
    Gastroenterology; 2014 Feb 05; 146(2):392-400.e3. PubMed ID: 24512909
    [Abstract] [Full Text] [Related]

  • 12. C1-inhibitor Deficiency Induces Myositis-like Symptoms Via the Deposition of the Membrane Attack Complex in the Muscle.
    Beck G, Yamashita R, Saeki C, Ogawa T, Shimizu M, Mochizuki H.
    Intern Med; 2020 Sep 01; 59(17):2173-2176. PubMed ID: 32461528
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A case of granulomatous myositis in a patient with rheumatoid arthritis receiving anti-TNF-α treatment.
    Kawamura A, Tsuchida Y, Shoda H, Kubo K, Uchio N, Shimizu J, Fujio K.
    Mod Rheumatol Case Rep; 2020 Jan 01; 4(1):1-5. PubMed ID: 33086966
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Outpatient Ulcerative Colitis Primary Anti-TNF Responders Receiving Adalimumab or Infliximab Maintenance Therapy Have Similar Rates of Secondary Loss of Response.
    Ma C, Huang V, Fedorak DK, Kroeker KI, Dieleman LA, Halloran BP, Fedorak RN.
    J Clin Gastroenterol; 2015 Sep 01; 49(8):675-82. PubMed ID: 25389599
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anti-U3 ribonucleoprotein antibody-positive inflammatory myopathy: a case report.
    Murata KY, Nakatani K, Yananeki M, Nakanishi I, Ito H.
    J Med Case Rep; 2016 Jun 09; 10():169. PubMed ID: 27283724
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.